Physician
Salem Clinic, PC
Salem Clinic, PC was paid $28.32M by Medicaid between Jan 2018 and Dec 2024, across 158 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 51% of everything it billed.
33Billing provider infoSALEM CLINIC, PC
SALEM, OR 97303
SALEM, OR 97303
33aNPI1912935594assigned 06/30/2006
33bProvider typeGeneral Practice Physician
28Total paid$28.32M
24GClaims674,433
24DCodes billed158
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Practice Physician providers in Oregon
Rank by total paid#4 of 23
Median peer was paid$112K
This provider vs. median254×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 138,404 | $366K | |
| 2019 | 130,758 | $382K | |
| 2020 | 91,624 | $5.47M | |
| 2021 | 92,381 | $6.06M | |
| 2022 | 85,137 | $5.70M | |
| 2023 | 74,476 | $5.22M | |
| 2024incomplete | 61,653 | $5.11M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 51% | 203,158 | 181,739 | $14.32M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 29% | 67,415 | 58,060 | $8.20M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 5.1% | 7,529 | 7,207 | $1.45M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.6% | 6,319 | 5,968 | $454K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1.5% | 3,990 | 3,784 | $414K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.5% | 9,700 | 9,373 | $411K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 1.4% | 10,777 | 4,016 | $388K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 2,064 | 1,962 | $215K |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | <1% | 1,714 | 1,482 | $196K |
| 36415 | Collection of venous blood by venipuncture | <1% | 99,987 | 86,678 | $164K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 2,849 | 2,753 | $143K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | <1% | 594 | 528 | $131K |
146 more codes
| 96160 | <1% | 28,407 | $106K | |
| 80053 | Comprehensive metabolic panel | <1% | 29,506 | $102K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 7,880 | $98K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 382 | $96K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 4,560 | $90K |
| 59025 | Fetal non-stress test | <1% | 1,571 | $80K |
| 90686 | <1% | 5,709 | $77K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 2,524 | $72K |
| 80061 | Lipid panel | <1% | 15,680 | $72K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 8,298 | $71K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 373 | $64K |
| 83721 | <1% | 16,075 | $58K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 335 | $57K |
| 96156 | <1% | 754 | $52K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 15,294 | $50K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 419 | $42K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 17,199 | $39K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 554 | $36K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 204 | $36K |
| 90682 | <1% | 1,407 | $36K | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 4,492 | $31K |
| 76830 | Ultrasound, transvaginal | <1% | 310 | $29K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,946 | $29K |
| 80050 | General health panel | <1% | 2,165 | $29K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 2,893 | $27K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 699 | $24K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,172 | $18K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 1,003 | $17K |
| 96158 | <1% | 325 | $16K | |
| 90673 | <1% | 312 | $16K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,334 | $15K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,376 | $15K |
| 99406 | <1% | 567 | $15K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 470 | $14K |
| 81514 | <1% | 69 | $12K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 632 | $11K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,596 | $11K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 452 | $10K |
| 76801 | <1% | 105 | $10K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 146 | $10K |
| 82607 | <1% | 1,809 | $9K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 53 | $9K |
| 86780 | <1% | 1,675 | $8K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 65 | $7K |
| 99223 | Prolong inpt eval add15 m | <1% | 44 | $7K |
| 99201 | <1% | 80 | $6K | |
| 82728 | <1% | 1,482 | $6K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,937 | $6K |
| 87480 | <1% | 1,463 | $6K | |
| 87510 | <1% | 1,460 | $6K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 428 | $5K |
| 81001 | <1% | 3,997 | $4K | |
| 87653 | <1% | 318 | $4K | |
| 90688 | <1% | 3,296 | $4K | |
| 87660 | <1% | 1,460 | $4K | |
| 83550 | <1% | 801 | $4K | |
| 0124A | <1% | 148 | $3K | |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | <1% | 866 | $3K |
| 86803 | <1% | 640 | $3K | |
| 83540 | <1% | 843 | $3K | |
| 90677 | <1% | 13 | $3K | |
| 98968 | <1% | 43 | $2K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 214 | $2K |
| 85027 | <1% | 635 | $2K | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 13 | $2K |
| G0127 | Trimming of dystrophic nails, any number | <1% | 168 | $2K |
| 99441 | <1% | 92 | $2K | |
| 95251 | <1% | 29 | $2K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 51 | $2K |
| 90651 | <1% | 230 | $2K | |
| 72100 | <1% | 38 | $1K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 705 | $1K |
| 99442 | <1% | 35 | $1K | |
| 87070 | <1% | 971 | $1K | |
| 82570 | <1% | 1,356 | $933.89 | |
| 91320 | <1% | 12 | $913.00 | |
| 73564 | <1% | 13 | $893.24 | |
| 98967 | <1% | 18 | $892.80 | |
| 96150 | <1% | 1,579 | $869.46 | |
| 0054A | <1% | 24 | $691.00 | |
| 82043 | <1% | 1,187 | $678.64 | |
| 87081 | <1% | 283 | $649.08 | |
| J1071 | Injection, testosterone cypionate, 1 mg | <1% | 1,028 | $525.58 |
| 82950 | <1% | 289 | $496.07 | |
| 87186 | <1% | 308 | $472.14 | |
| 90670 | <1% | 393 | $461.16 | |
| 81003 | <1% | 810 | $450.95 | |
| 87077 | <1% | 306 | $441.29 | |
| 84439 | <1% | 124 | $376.33 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,050 | $339.83 |
| 86850 | <1% | 78 | $311.74 | |
| 81025 | <1% | 367 | $310.35 | |
| 90715 | <1% | 191 | $223.17 | |
| 85652 | <1% | 158 | $206.69 | |
| 87340 | <1% | 38 | $202.98 | |
| 99221 | <1% | 25 | $155.54 | |
| 96152 | <1% | 808 | $145.38 | |
| 87807 | <1% | 15 | $124.02 | |
| 86762 | <1% | 14 | $120.64 | |
| 90732 | <1% | 28 | $107.75 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 318 | $102.85 |
| 86900 | <1% | 51 | $89.68 | |
| 82274 | <1% | 202 | $78.36 | |
| 87210 | <1% | 50 | $77.73 | |
| 90633 | <1% | 130 | $65.88 | |
| 90685 | <1% | 47 | $65.88 | |
| 86703 | <1% | 31 | $65.15 | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 29 | $53.30 |
| 86901 | <1% | 25 | $48.42 | |
| G0008 | Administration of influenza virus vaccine | <1% | 784 | $46.83 |
| 96154 | <1% | 29 | $45.92 | |
| 90698 | <1% | 166 | $43.92 | |
| 84156 | <1% | 29 | $35.72 | |
| 87205 | <1% | 46 | $22.14 | |
| 87338 | <1% | 13 | $12.43 | |
| 83690 | <1% | 26 | $11.91 | |
| 82150 | <1% | 13 | $5.04 | |
| 82248 | <1% | 57 | $4.82 | |
| 99001 | <1% | 36 | $4.19 | |
| 3074F | <1% | 2,842 | $0.01 | |
| 3078F | <1% | 2,790 | $0.01 | |
| 0503F | 0% | 826 | $0.00 | |
| 3079F | 0% | 1,367 | $0.00 | |
| 90744 | 0% | 95 | $0.00 | |
| 99024 | 0% | 881 | $0.00 | |
| 3075F | 0% | 464 | $0.00 | |
| 1123F | 0% | 499 | $0.00 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 0% | 13 | $0.00 |
| 77063 | Screening digital breast tomosynthesis, bilateral | 0% | 57 | $0.00 |
| 0500F | 0% | 29 | $0.00 | |
| 3080F | 0% | 46 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 26 | $0.00 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 0% | 14 | $0.00 |
| 0501F | 0% | 12 | $0.00 | |
| 90696 | 0% | 13 | $0.00 | |
| 90680 | 0% | 26 | $0.00 | |
| 84703 | 0% | 15 | $0.00 | |
| 0502F | 0% | 26,881 | $0.00 | |
| 1159F | 0% | 259 | $0.00 | |
| 3077F | 0% | 141 | $0.00 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 0% | 28 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 17 | $0.00 |
| 90734 | 0% | 38 | $0.00 | |
| 90710 | 0% | 41 | $0.00 | |
| 90750 | 0% | 12 | $0.00 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 24 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGUNDER, BARBARA (ADMINISTRATOR/CAO)